A global trial designed to test whether the anti-malaria drugs hydroxychloroquine and chloroquine can prevent infection with COVID-19 is to restart after being approved by British regulators.
The World Health Organization was moving to update guidelines on treating people stricken with COVID-19 to reflect results of a clinical trial that showed a cheap, common steroid can help save critically ill patients.
A cheap and widely used steroid called dexamethasone has become the first drug shown to be able to save lives among COVID-19 patients in what scientists said is a “major breakthrough” in the coronavirus pandemic.
AstraZeneca Plc signed a contract with European governments to supply the region with a potential vaccine against the coronavirus, the British drugmaker’s latest deal to pledge the company’s drug to help combat the pandemic.
MADRID (Reuters) – The leaders of six European Union nations have called for building up EU stocks of critical medicines and equipment and other measures to boost the bloc’s long-term resilience to public health crises. The 27-nation EU and Britain have reported some 1.4 million cases of the new coronavirus, or about a fifth of […]
The European Union urged the United States to reconsider its decision to cut ties with the World Health Organization over its handling of the coronavirus pandemic
Children have milder COVID-19 symptoms than adults and the balance of evidence suggests they may also have lower susceptibility and infectivity than adults, scientists advising the British government said.
Oxford University and AstraZeneca are recruiting around 10,000 adults and children in Britain for trials of an experimental coronavirus vaccine, a day after receiving U.S. backing worth up to $1.2 billion.
Healthcare workers in Britain and Thailand started taking part in a trial to determine whether two anti-malarial drugs can prevent COVID-19, including one that U.S. President Donald Trump says he has been taking.
Britain is in talks with Swiss drugmaker Roche Holding AG to buy an accurate COVID-19 antibody test, following the lead of the European Union and United States, which had already given preliminary approval to the tests.